semaglutide cardiovascular outcomes news today and in Obesity without Diabetes Semaglutide Effects on Cardiovascular Outcomes

Schulte-Hermann, R., and Parzefall, W

Patel says the retatrutide discussion should serve as a reminder that ongoing patient-doctor communication is vital with any weight loss drug

It does cover Ozempic (semaglutide), though, another Type 2 diabetes medication that can help with weight loss

In general, GIPR-Ab/GLP- 1 molecules encourage body weight loss and have potential applications in the treatment of obesity [81]

However, both affect metabolism and cardiovascular function, so baseline and periodic labsincluding testosterone levels, hemoglobin, lipids, and blood pressureare essential

Think of it like this: GLP-1 friendly = supports fullness and stable energy